Grant Resources

More rat-related grants are good news for all of us so we're assembling some information and other resources that might be of help as you plan and write your grants. This is certainly a work in progress so please feel free to contact us with more suggestions and requests for ways in which RGD can help you in your grant writing.

 

Rat Data and Statistics 

The RGD Curation team has a great deal of experience finding and compiling rat data and we may be able to help you find information or even create specific datasets for your grant or publication.

Some past examples:

 

Current Rat data statistics from NCBI 

You can use the following search term at NCBI to narrow your searches to Rat data: txid10116[orgn] OR "rattus norvegicus" [Run this query at NCBI now]. 

 

Data Sharing Plan

RGD makes data readily available to users through the download function within each tool or through the FTP site.  We welcome working with investigators and groups looking to build data pipelines for other tools.  Customized data sets are also available upon request.

Most NIH grants now contain a section covering the Sharing of Research Data (eg. RO1, Section 2.C.) which requires applicants to describe their plans for sharing data that is created as part of the proposed research. RGD may well be able to act as a suitable venue for project data to be made available to the research community and we encourage researchers to contact us to discuss this further. Strain, QTL, and gene registration can be done through our submission forms.  Direct submission of new data, or additions and revisions to existing data in RGD are welcome. Please contact Mary Shimoyama, PhD (shimoyama@mcw.edu) for these types of data submissions.

Software Sharing Plan

RGD uses two open source tools (GBrowse and RatMine). Information regarding access to these tools should be obtained directly from GMOD (Generic Model Organism Database project, http://gmod.org/wiki/GBrowse) for GBrowse or InterMine (http://intermine.github.io/intermine.org/) for RatMine. 

For all other software code, please contact us directly for information and access to the code.

Model Organism Sharing Plan

Most NIH grants now also contain a section covering the Sharing of Research Resources (eg. RO1, Section 2.D.) which requires applicants to describe their plans for sharing "unique research resources" that are created as part of the proposed research (see NIH Grants Policy Statement for more information). This includes a Model Organism Sharing Plan that should describe how unique animal models created through the funded research will be made available to the community.

While RGD is unable to help directly with the sharing of biological resources, investigators are encourage to contact groups such as the Rat Resource and Research Center (RRRC) in Missouri, US or the National BioResource Project (NBRP) in Kyoto, Japan, for information about their rat strain repository facilities.

NIH Funding Opportunities (Notices, PA, RFA)

Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
  • Limited Competition: Research Resource for Systematic Reviews of Complementary and Integrative Health (R24) - Funding Opportunity RFA-AT-17-003 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA), issued by the National Center for Complementary and Integrative Health (NCCIH), seeks to solicit limited applications for continuation of an established research resource consisting of a database of primary reports of the full spectrum of complementary and integrative health controlled clinical trials. This resource will facilitate the conduct of high quality systematic reviews and when possible meta-analyses of published reports of clinical trials of complementary and integrative health treatments and interventions. The review of all published controlled clinical trials on a given topic and summary of the results in a systematic and unbiased manner provide a current best evidence for health care practitioners, patients, health care policy makers and research administration. In addition, the resource will ensure and promote access and availability to the broader scientific community and provide editorial, methodological and technical support to those utilizing the resource for systematic reviews. Applications must address the following: justification regarding why continued funding is needed from NIH; plans for maintenance of a research resource consisting of a complementary and integrative health controlled clinical trials database; plans to ensure access and availability of the resource to the scientific community; address updates of current reviews in the database; conduct of a minimum of one new and update two existing NCCIH strategic plan-related systematic reviews per year and when possible meta-analyses; and methods the investigators will use to identify new reviews and updates that align with NCCIH strategic priorities, particularly evaluating the effectiveness of mind and body complementary interventions for pain conditions.
  • Academic Development of a Training Program for Good Laboratory Practices in High Containment Environments (U24) - Funding Opportunity RFA-FD-17-013 from the NIH Guide for Grants and Contracts. The Food and Drug Administration (FDA) is announcing the availability of cooperative agreement funds for the support of a Funding Opportunity Announcement (FOA) entitled "Academic Development of a Training Program for Good Laboratory Practices in High Containment Environments (U24).' In this FOA, FDA announces its intention to accept and consider a single source application for an award to the University of Texas Medical Branch (UTMB) Galveston National Laboratory (GNL) for the development and implementation of a certified, academic training course for instruction in Good Laboratory Practices (GLP) in a Biosafety Level (BSL) 4 High Containment Environment. FDA seeks to support an effort to design a robust, collaborative, and educational program using problem-based learning techniques designed to bring researchers and regulators together to educate each other on the challenges related to these issues and to identify solutions that are acceptable from both scientific and regulatory perspectives.
  • Global Pediatric Clinical Trials Network (U18) - Funding Opportunity RFA-FD-17-014 from the NIH Guide for Grants and Contracts. The goals of this program are to support the development of the scientific infrastructure needed to plan and execute pediatric clinical trials through collaboration with stakeholders from academia, industry, parent/patient advocacy groups, and government agencies. The Global Pediatric Trial Network should be a coordinating resource for pediatric product development with sustainable global infrastructure to plan, start up, conduct, and close out pediatric clinical investigations. There should be an emphasis on operational efficiency and network sustainability with early, systematic, and integrative approaches to pediatric studies.
  • Centers of Excellence in Ethical, Legal and Social Implications (ELSI) Research (CEER) (RM1) - Funding Opportunity RFA-HG-17-006 from the NIH Guide for Grants and Contracts. The National Human Genome Research Institute (NHGRI) is soliciting grant applications for the support of Centers of Excellence in Ethical, Legal and Social Implications (ELSI) Research (CEERs). The CEER Program is designed to support the establishment of sustainable trans-disciplinary research teams with the expertise and flexibility to anticipate, conduct research on, and quickly address a range of cutting edge ethical, legal, and social issues related to genetics and genomics. The Program is intended to create new research opportunities that cross disciplinary boundaries among investigators in diverse fields, such as the genomic sciences, clinical research, clinical and health policy, ethics, law, the humanities, economics, political science, anthropology and other social sciences. In addition to conducting trans-disciplinary research, Centers will disseminate their research findings as well as facilitate the use of their findings to develop relevant research, health and public policies and practices. Finally, Centers will contribute to developing the next generation of ELSI researchers.